Luke Nathaniel Walker - Insider Trading & Ownership

Entity
Individual
Location
C/O Cascadian Therapeutics, Inc., 3101 Western Ave., Suite 600, Seattle, WA
Summary
The estimated net worth of Luke Nathaniel Walker is at least $915K dollars as of September 5, 2024. Luke Nathaniel Walker is the Director of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $915K.
All Insider Reports
All Insider Reports

Ownership of Luke Nathaniel Walker

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ZNTL Zentalis Pharmaceuticals, Inc. Director $915K May 24, 2024
CNTX Context Therapeutics Inc. Director Sep 4, 2024
HARP Harpoon Therapeutics, Inc. Chief Medical Officer Mar 11, 2024

Insider Transactions Reported by Luke Nathaniel Walker:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.